Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The inspection is now closed, and no regulatory action has been recommended
This inspection is now closed
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
This relates to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States
The positive outcome clears the way for Glenmark to resume commercial manufacturing at the site
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
Subscribe To Our Newsletter & Stay Updated